CVS Health (NYSE:CVS) Price Target Lowered to $90.00 at Argus

CVS Health (NYSE:CVS) had its target price trimmed by Argus from $91.00 to $90.00 in a research note released on Wednesday, MarketBeat.com reports. The brokerage currently has a buy rating on the pharmacy operator’s stock.

CVS has been the topic of a number of other reports. Truist Financial set a $100.00 target price on shares of CVS Health in a research report on Wednesday, December 10th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Raymond James Financial boosted their price target on CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Finally, UBS Group restated an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.82.

CVS Health Trading Up 3.0%

Shares of CVS opened at $74.14 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health has a 12 month low of $53.36 and a 12 month high of $85.15. The stock has a market cap of $94.12 billion, a PE ratio of 195.11, a P/E/G ratio of 0.66 and a beta of 0.48. The stock’s 50-day moving average is $79.01 and its two-hundred day moving average is $75.02.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s revenue was up 7.8% on a year-over-year basis. During the same period last year, the business posted $1.09 EPS. Equities analysts forecast that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.6%. CVS Health’s payout ratio is 700.00%.

Hedge Funds Weigh In On CVS Health

A number of large investors have recently bought and sold shares of the business. Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares during the last quarter. Alpha Omega Wealth Management LLC boosted its position in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares during the period. Aaron Wealth Advisors LLC grew its stake in shares of CVS Health by 177.4% in the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after acquiring an additional 21,911 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in CVS Health by 186.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock worth $30,568,000 after acquiring an additional 258,050 shares during the period. Finally, Red Mountain Financial LLC acquired a new position in CVS Health during the 2nd quarter valued at $293,000. Institutional investors own 80.66% of the company’s stock.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS shares rose while the broader market fell, reflecting short-term buying interest and risk-on flows. Zacks Article
• Positive Sentiment: Short interest fell ~13.4% in January to ~18.76M shares (1.5% of float), lowering potential downward pressure from short sellers and reducing squeeze risk (days-to-cover ~2.5). Short Interest Data
• Positive Sentiment: An executive vice president disclosed a small open-market buy (24 shares at ~$53.70 on Jan. 23), a modest insider signal of confidence. SEC Form 4
• Neutral Sentiment: Analysts at Argus cut their price target slightly from $91 to $90 but kept a “buy” rating (still showing material upside), signaling continued analyst support despite the trim. The Fly
• Neutral Sentiment: Bank of America lowered its target from $100 to $95 but maintained a “buy” stance, also implying continued conviction in longer-term upside despite near-term adjustments. Benzinga
• Negative Sentiment: The administration’s proposal to keep Medicare rates roughly flat has pressured Medicare-related revenue expectations for payers and pharmacy benefit managers, contributing to earlier selloffs and ongoing margin concerns for CVS. Barron’s
• Negative Sentiment: A House Judiciary report and related coverage allege CVS used tactics to limit competition from rival pharmacy hubs, introducing regulatory and legal risk that could increase compliance costs or fines. HealthcareDive

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.